(Q43754379)

26 November 2017

title

The effects of tegaserod (HTF 919) on the pharmacokinetics and pharmacodynamics of digoxin in healthy subjects (English)

1 reference

26 November 2017

0 references

1 reference

Zhou H

1

1 reference

26 November 2017

Horowitz A

2

1 reference

26 November 2017

Ledford PC

3

1 reference

26 November 2017

Hubert M

4

1 reference

26 November 2017

Appel-Dingemanse S

5

1 reference

26 November 2017

Osborne S

6

1 reference

26 November 2017

McLeod JF

7

1 reference

26 November 2017

language of work or name

1 reference

1 October 2001

1 reference

The Journal of Clinical Pharmacology

26 November 2017

published in

1 reference

26 November 2017

volume

41

1 reference

26 November 2017

issue

10

1 reference

26 November 2017

page(s)

1131-1139

1 reference

The serotonin 5-HT4 receptor. 1. Design of a new class of agonists and receptor map of the agonist recognition site.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

The Serotonin 5-HT4 Receptor. 2. Structure-Activity Studies of the Indole Carbazimidamide Class of Agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

Pharmacokinetic drug interactions with gastrointestinal motility modifying agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

Effect of meal timing not critical for the pharmacokinetics of tegaserod (HTF 919).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

Integrated modelling of the clinical pharmacokinetics of SDZ HTF 919, a novel selective 5-HT4 receptor agonist, following oral and intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

Absorption of digoxin from the distal parts of the intestine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

Effect of metoclopramide on digoxin absorption from tablets and capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

Altered absorption of digoxin in patients given propantheline and metoclopramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

Effect of cisapride and metoclopramide on digoxin bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

First pharmacokinetic-pharmacodynamic study in humans with a selective 5-hydroxytryptamine4 receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

Clinical implications of serum digoxin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700122012625

10.1177/00912700122012625

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference